Akouos (AKUS) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 85 253 sessions, November 30, 2021 to November 30, 2022
- Largest daily move
- +88.2% close of October 18, 2022
- 1-year change
- +72.8% closing prices, November 30, 2021 to November 30, 2022
Company Description
Akouos (NASDAQ: AKUS) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $491.0M.
AKUS has gained 72.8% over the past year. The last closing price was $13.29.
This page collects what Stock Titan holds for AKUS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Akouos (AKUS) closed at $13.29 on November 30, 2022. Over the past 12 months, the price has gained 72.8%.
AKUS Metrics & Rankings
Price returns through November 30, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Akouos has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, earnings, clinical trial, fda approval, conferences. View all AKUS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AKUS Company Profile & Sector Positioning
Akouos (AKUS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing AKUS often look at related companies in the same sector, including aTyr Pharma, Inc. (ATYR), Arcturus Therapeutics Holdings Inc. (ARCT), Bicycle Therapeutics plc (BCYC), REGENXBIO Inc. (RGNX), and Nanobiotix S.A. (NBTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AKUS's relative position within its industry.